Trials / Suspended
SuspendedNCT00668798
Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms
Incidence and Clinical Outcome of Human Cytomegalovirus Transmission Via Thawed Frozen Breast Milk in Preterm Infants <31 Weeks. A Prospective Trial.
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- Johann Wolfgang Goethe University Hospital · Academic / Other
- Sex
- All
- Age
- 24 Weeks – 31 Weeks
- Healthy volunteers
- Not accepted
Summary
Cytomegalovirus infection threatens preterm infant. We investigated, whether thawed breast milk is a mode of transmission
Detailed description
Preterm infants are at risk of symptomatic human cytomegalovirus infections transmitted by breast milk. This study evaluates incidence, timing, and clinical rlevance of acquired human CMV infections in preterm infants younger than 32 weeks of gestational age receiving maternal thawed frozen breast milk until 33 completed weeks of gestational age.
Conditions
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2008-01-01
- Completion
- 2008-03-01
- First posted
- 2008-04-29
- Last updated
- 2008-04-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00668798. Inclusion in this directory is not an endorsement.